Sign in

CIK 0001501989 · Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273521219
Phone
650.515.3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. DEF 14A Proxy Proxy Statement
  2. PRE 14A Proxy Proxy Statement (Preliminary)
  3. DEF 14A Proxy Proxy Statement
  4. DEF 14A Proxy Proxy Statement
  5. PRE 14A Proxy Proxy Statement (Preliminary)
  6. DEF 14A Proxy Proxy Statement
  7. DEF 14A Proxy Proxy Statement
  8. DEF 14A Proxy Proxy Statement
  9. DEF 14A Proxy Proxy Statement
  10. PRE 14A Proxy Proxy Statement (Preliminary)
  11. DEF 14A Proxy Proxy Statement
  12. DEF 14A Proxy Proxy Statement
  13. DEF 14A Proxy Proxy Statement
  14. DEF 14A Proxy Proxy Statement

Page 1 of 1 · 14 filings